Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87,874 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype].
Huang AJ, Gao L, Ni X, Hu XX, Tang GS, Cheng H, Chen J, Chen L, Liu LX, Wang CC, Zhang WP, Yang JM, Wang JM. Huang AJ, et al. Among authors: zhang wp. Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):420-424. doi: 10.3760/cma.j.issn.0253-2727.2021.05.012. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 35790467 Free PMC article. Chinese. No abstract available.
[Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations].
Zhang Y, Zhang YM, Zhang YS, Tang GS, Zhang WP, Yang JM, Wang JM, Hu XX. Zhang Y, et al. Among authors: zhang ym, zhang ys, zhang wp. Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):597-601. doi: 10.3760/cma.j.issn.0253-2727.2019.07.012. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32397025 Free PMC article. Chinese. No abstract available.
[Minimal residual disease before post-remission therapy predicts outcomes in younger adult with intermediate-risk acute myeloid leukemia].
Zhang Y, Zhang YM, Chen Q, Tang GS, Qiu HY, Gao L, Chen J, Ni X, Chen L, Zhang WP, Yang JM, Wang JM, Hu XX. Zhang Y, et al. Among authors: zhang ym, zhang wp. Zhonghua Xue Ye Xue Za Zhi. 2019 Feb 14;40(2):147-151. doi: 10.3760/cma.j.issn.0253-2727.2019.02.011. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 30831632 Free PMC article. Chinese. No abstract available.
[Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].
Zhang YM, Zhang Y, Ni X, Gao L, Qiu HY, Zhang YS, Tang GS, Chen J, Zhang WP, Wang JM, Yang JM, Hu XX. Zhang YM, et al. Among authors: zhang ys, zhang wp, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):16-22. doi: 10.3760/cma.j.issn.0253-2727.2020.01.004. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32023749 Free PMC article. Chinese.
[Extramedually biliary relapse of Ph positive B lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a case report].
Fu WJ, Hu XX, Wang LB, Zhang Y, Yang D, Zhang WP, Chen J, Wang JM, Yang JM. Fu WJ, et al. Among authors: zhang wp, zhang y. Zhonghua Xue Ye Xue Za Zhi. 2019 Oct 14;40(10):879. doi: 10.3760/cma.j.issn.0253-2727.2019.10.019. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31775494 Free PMC article. Chinese. No abstract available.
[Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia].
Fei Y, Hu XX, Chen Q, Huang AJ, Cheng H, Ni X, Qiu HY, Gao L, Tang GS, Chen J, Zhang WP, Yang JM, Wang JM. Fei Y, et al. Among authors: zhang wp. Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):990-995. doi: 10.3760/cma.j.issn.0253-2727.2019.12.004. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32023728 Free PMC article. Chinese.
87,874 results
You have reached the last available page of results. Please see the User Guide for more information.